Art

J-GLOBAL ID：200902157910758860   Reference number：01A0079133

血液疾患の動向 悪性リンパ腫の化学療法と成績

Author (1)： MORI HIROSHI (昭和大 藤が丘病院)
Material： 昭和医学会雑誌  (Journal of the Showa Medical Association)
Volume： 60  Issue： 4  Page： 443-447  Publication year： Aug. 28, 2000 
JST Material Number： Z0096B  ISSN： 0037-4342  CODEN： SIGZAL  Document type： Article
Article type： 解説  Country of issue： Japan (JPN)  Language： JAPANESE (JA)

Thesaurus term： *lymphoma ,...

   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=01A0079133&from=J-GLOBAL&jstjournalNo=Z0096B") }}

JST classification (1)： Drug therapy(=pharmacotherapy)for tumors  (GE03032C)

Reference (10)：

• 1) Santoro A, Viviani S, Villarreal CJR, et al: Salvage chemotherapy in Hodgkin's disease irradiation failures: Superiority of doxorubicin-containing regimens over MOPP. Cancer Treat Rep 70: 343-348, 1986.
• 2) Canellos GP, Anderson JR, Propert KJ, et al: Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD. N Engl J Med 327: 1478-1488, 1992.
• 3) Rosenberg SA: The low-grade non-Hodgkin's lymphomas: Challenges and opportunities. J Clin Oncol 3: 299-310, 1985.
• 4) Tobinai K, Kobayasi Y, Narabayashi M, et al: Feasibility and pharmacokinetic study of a chimeric anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab) in relapsed B-cell lymphoma. Ann Oncol 9: 527-534, 1998.
• 5) Fisher RI, Gaynor ER, Dahlberg S, et al: Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med 328: 1002-1006, 1993.

Terms in the title (5)： 血液疾患 ,  動向 ,  悪性リンパ腫 ,  化学療法 ,  成績